Modified human hepatitis c virus genomic rna having autonomous replicative competence

It is intended to provide a modified hepatitis C virus genomic RNA having a base sequence containing the 5'-nontranslated region, core protein-encoding sequence, E1 protein-encoding sequence, p7 protein-encoding sequence, E2 protein-encoding sequence, NS2 protein-encoding sequence, NS3 protein-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: WAKITA TAKAJI,KATO TAKANOBU,DATE TOMOKO,MIYAMOTO MICHIKO,BARTENSCHLAGER RALF,TANABE JUN ICHI,SONE SABURO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It is intended to provide a modified hepatitis C virus genomic RNA having a base sequence containing the 5'-nontranslated region, core protein-encoding sequence, E1 protein-encoding sequence, p7 protein-encoding sequence, E2 protein-encoding sequence, NS2 protein-encoding sequence, NS3 protein-encoding sequence, NS4A protein-encoding sequence, NS4B protein-encoding sequence, NS5A protein-encoding sequence, NS5B protein-encoding sequence and 3'-nontransalated region of two or more hepatitis C virus genomic RNAs and having autonomous replicative competence. In particular, a modified hepatitis C virus genomic RNA which has acquired the autonomous replicative competence via the substitution of a partial RNA sequence encoding NS3 to NS4, NS5A and NS5B proteins in a hepatitis C virus genomic RNA by the partial RNA sequence encoding NS3 to NS4, NS5A and NS5B proteins of JFH1 strain represented by SEQ ID NO:1.